The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Cognitive impairments four months after COVID-19 hospital discharge: pattern, severity and association with illness variables.
Open accessAbstract
The ongoing Coronavirus Disease 2019 (COVID-19) pandemic has affected more than 100 million people and clinics are being established for diagnosing and treating lingering symptoms, so called long-COVID. A key concern are neurological and long-term cognitive complications. At the same time, the prevalence and nature of the cognitive sequalae of COVID-19 are unclear. The present study aimed to investigate the frequency, pattern and severity of cognitive impairments 3-4 months after COVID-19 hospital discharge, their relation to subjective cognitive complaints, quality of life and illness variables. We recruited patients at their follow-up visit at the respiratory outpatient clinic, Copenhagen University Hospital, Bispebjerg, approximately four months after hospitalisation with COVID-19. Patients underwent pulmonary, functional and cognitive assessments. Twenty-nine patients were included. The percentage of patients with clinically significant cognitive impairment ranged from 59% to 65% depending on the applied cut-off for clinical relevance of cognitive impairment, with verbal learning and executive functions being most affected. Objective cognitive impairment scaled with subjective cognitive complaints, lower work function and poorer quality of life. Cognitive impairments were associated with d-dimer levels during acute illness and residual pulmonary dysfunction. In conclusion, these findings provide new evidence for frequent cognitive sequelae of COVID-19 and indicate an association with the severity of the lung affection and potentially restricted cerebral oxygen delivery. Further, the associations with quality of life and functioning call for systematic cognitive screening of patients after recovery from severe COVID-19 illness and implementation of targeted treatments for patients with persistent cognitive impairments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The association between IQCODE and TICS-40 scores was analyzed to ensure the consistency of the 2 cognitive assessments verified in previous studies.20,21”
From One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study (2022) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., Kang, L., Guo, L., Liu, M., Zhou, X., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32656-8 · Cited by 4,084
RetractedNeurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166
Celli, B. R., MacNee, W., Agustí, A. G. N., Anzueto, A. R., Berg, B., Buist, A. S., Calverley, P. M., Chavannes, N. H., Dillard, T. A., Fahy, B. F., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,410
The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument
Reilly, M. C., Zbrozek, A. S., & Dukes, E. M. (1993) · PharmacoEconomics · doi:10.2165/00019053-199304050-00006 · Cited by 3,071
The Cognitive Failures Questionnaire (CFQ) and its correlates
Broadbent, D. E., Cooper, P. F., FitzGerald, P., & Parkes, K. R. (1982) · British Journal of Clinical Psychology · doi:10.1111/j.2044-8260.1982.tb01421.x · Cited by 3,054
Neurologic features in severe SARS-CoV-2 infection
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2008597 · Cited by 2,674
Development and validation of a questionnaire to measure asthma control
Juniper, E. F., O′byrne, P. M., Guyatt, G. H., Ferrie, P. J., & King, D. R. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14d29.x · Cited by 2,473
Li, Y., Bai, W., & Hashikawa, T. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25728 · Cited by 2,266
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
Oxley, T. J., Mocco, J., Majidi, S., Kellner, C. P., Shoirah, H., Singh, I. P., Leacy, R. A. D., Shigematsu, T., Ladner, T. R., Yaeger, K., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009787 · Cited by 2,114
Nervous system involvement after infection with COVID-19 and other coronaviruses
Wu, Y., Xu, X., Chen, Z., Duan, J., Hashimoto, K., Yang, L., Liu, C., & Yang, C. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.03.031 · Cited by 2,046
Cited by
Sorted by citations
Items 101–200 of 363
Feltz-Cornelis, C. M. V. D., Sweetman, J., Allsopp, G. M., Attree, E., Crooks, M. G., Cuthbertson, D. J., Forshaw, D., Gabbay, M., Green, A., Heightman, M., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277936 · Cited by 18
“(14) Multi-organ complications,(13, 15-18) including neuropsychiatric sequelae (up to 20%), are well-documented.”
BackgroundCognitive Complaints Assessment and Neuropsychiatric Disorders After Mild COVID-19 Infection
Hämmerle, M. B., Sales, D. S., Pinheiro, P. G., Gutman, E. G., de Almeida, P. I. F. M., Davico, C. D. A., Souza, R. S., Spedo, C. T., Nicaretta, D. H., Alvarenga, R. M. P., et al. (2022) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acac093 · Cited by 18
Long COVID neuropsychological follow-up: Is cognitive rehabilitation relevant?
Braga, L. W., de Oliveira, S. B., Moreira, A. S., Pereira, M. E. M. D. S. M., Serio, A., Carneiro, V. D. S., Freitas, L. D. F. P., & Souza, L. M. D. N. (2023) · Neurorehabilitation · doi:10.3233/nre-230212 · Cited by 20
Structural brain changes in post-COVID condition and its relationship with cognitive impairment
Pacheco-Jaime, L., Garcia-Vicente, C., Ariza, M., Cano, N., Garolera, M., Carreras-Vidal, L., Roura, I., Capdevila-Lacasa, C., Oltra, J., Pardo, J., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcaf070 · Cited by 19
“In addition to cognitive measures, we used the Chalder fatigue scale 44 to assess fatigue, the generalized anxiety disorder 7-item scale 45 to assess anxiety, the Patient Health Questionnaire-9 46 to assess depression and memory failures of everyday test 47 to assess subjective memory complains.”
InfluentialBegemann, M., Groß, O., Wincewicz, D., Hardeland, R., Gastaldi, V. D., Vieta, E., Weißenborn, K., Miskowiak, K. W., Moerer, O., & Ehrenreich, H. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00381-5 · Cited by 18
Self-citationMaiorana, N. V., Aiello, E. N., Poletti, B., Carusi, F., Sandi, A. D., Guidetti, M., Prandin, R., Marceglia, S. R. F., Ticozzi, N., Silani, V., et al. (2023) · Healthcare · doi:10.3390/healthcare11030284 · Cited by 17
Long-term cognitive dysfunction after the COVID-19 pandemic: a narrative review
Shariff, S., Uwishema, O., Mizero, J., Thambi, V. D., Nazir, A., Mahmoud, A., Kaushik, I., Khayat, S., Maigoro, A. Y., Awde, S., et al. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001265 · Cited by 19
“For instance, an investigative study on cognitive impairments 3 – 4 months post-COVID-19 hospital discharge found that 59 – 65% of subjects showed clinically signi fi cant cognitive impairment [13] .”
Frontera, J. A., Guekht, A. B., Allegri, R., Ashraf, M., Baykan, B. B., Crivelli, L., Easton, A., García‐Azorín, D., Helbok, R., Joshi, J., et al. (2023) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2023.120827 · Cited by 17
Chang, J. G., Ha, E.-H., Lee, W., & Lee, S. Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.994331 · Cited by 17
Long COVID: The impact on language and cognition
Cummings, L. (2023) · Language and Health · doi:10.1016/j.laheal.2023.05.001 · Cited by 16
Dawson, C., Clunie, G., Evison, F., Duncan, S., Whitney, J. C., Houchen‐Wolloff, L., Bolton, C. E., Leavy, O. C., Richardson, M., Omer, E., et al. (2023) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2023-001647 · Cited by 16
Saucier, J., Comeau, D., Robichaud, G. A., & Chamard-Witkowski, L. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1221266 · Cited by 16
Galderisi, S., Perrottelli, A., Giuliani, L., Pisaturo, M., Monteleone, P., Pagliano, P., Vita, A., Muiesan, M. L., Amore, M., Bassetti, M., et al. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.11.001 · Cited by 18
“…interval (from one month to 24 months) between the infection and the cognitive assessment represents another potential reason for discrepancies (Almeria et al., 2020; Becker et al., 2021; Evans et al., 2021; Hartung et al., 2022; Mattioli et al., 2022; Miskowiak et al., 2021; Voruz et al., 2022).”
BackgroundResultInfluentialCerebral Metabolic Rate of Glucose and Cognitive Tests in Long COVID Patients
Miskowiak, K. W., Bech, J. L., Henriksen, A. C., Johnsen, S., Podlekareva, D. N., & Marner, L. (2022) · Brain Sciences · doi:10.3390/brainsci13010023 · Cited by 16
Self-citationAgergaard, J., Ullahammer, W. M., Gunst, J. D., Østergaard, L. J., & Schiøttz‐Christensen, B. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11247338 · Cited by 16
Devita, M., Rosa, E. D., Iannizzi, P., Bianconi, S., Contin, S. A., Tiriolo, S., Ghisi, M., Schiavo, R., Bernardinello, N., Cocconcelli, E., et al. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.852218 · Cited by 15
Rocha, R. P. S., Andrade, A. C. D. S., Melanda, F. N., & Muraro, A. P. (2024) · Cadernos de Saúde Pública · doi:10.1590/0102-311xen027423 · Cited by 25
“Further research is needed to provide a better understanding of all neurological disorders associated with COVID-19 and their cognitive manifestations 36,37 .”
BackgroundGarcía-Grimshaw, M., Sankowski, R., & Valdés‐Ferrer, S. I. (2022) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001046 · Cited by 15
“In another study, residual pulmonary dysfunction 3– 4months after discharge was associated with cognitive impairment [94].”
BackgroundKognitive Störungen und Schlafstörungen bei Long-COVID
Schilling, C., Meyer‐Lindenberg, A., & Schweiger, J. I. (2022) · Der Nervenarzt · doi:10.1007/s00115-022-01297-z · Cited by 14
Luo, S., Lai, L. Y. H., Zhu, R., Gao, Y., & Zhao, Z. (2025) · Journal of Global Health · doi:10.7189/jogh.15.04282 · Cited by 16
Colzato, L. S., Elmers, J., Beste, C., & Hommel, B. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031198 · Cited by 15
Late neurological consequences of SARS-CoV-2 infection: New challenges for the neurologist
Korchut, A., & Rejdak, K. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1004957 · Cited by 13
“Time to identified symptoms, methods Miskowiak et al. (2021) Prospective study Denmark N: 29 H Cognitive impairment [17 (60”
MethodCOVID-19 and cognitive performance: a Mendelian randomization study
Tang, C.-M., Li, G. H., & Cheung, C. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1185957 · Cited by 13
Kozik, V., Reuken, P. A., Utech, I., Gramlich, J., Stallmach, Z., Demeyere, N., Rakers, F., Schwab, M. G., Stallmach, A., & Finke, K. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1233144 · Cited by 17
Virtual pulmonary rehabilitation approaches in patients with post COVID syndrome: a pilot study
Sarmento, A., Adodo, R. I., Hodges, G., Webber, S. C., & Sanchez‐Ramirez, D. C. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-02965-3 · Cited by 14
“The prevalence of fatigue and cognitive dysfunction, including memory and attention deficits, is high in individuals with PCS [59–61].”
BackgroundClinical management of COVID-19
World Health Organization (2025) · World Health Organization eBooks · doi:10.2471/b09467 · Cited by 18
Kopanczyk, R., Kumar, N., & Papadimos, T. J. (2021) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2021.09.051 · Cited by 13
Crook, H., Ramírez, A., Hosseini, A. A., Vavougios, G. D., Lehmann, C., Bruchfeld, J., Schneider, A., d’Avossa, G., Re, V. L., Salmoiraghi, A., et al. (2023) · Brain Connectivity · doi:10.1089/brain.2022.0058 · Cited by 12
“In hospitalized COVID-19 patients, overall cognitive impairment and executive dysfunction correlated with level of pulmonary function and severity of current respiratory symptoms (Miskowiak et al, 2021).”
Cognitive inhibition deficit in long COVID-19: An exploratory study
Saucier, J., José, C., Beroual, Z., Al-Qadi, M., Chartrand, S., Libert, E., Losier, M.-C., Cooling, K., Girouard, G., Jbilou, J., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1125574 · Cited by 14
Rocha, R. P. S., Andrade, A. C. D. S., Melanda, F. N., & Muraro, A. P. (2024) · Cadernos de Saúde Pública · doi:10.1590/0102-311xpt027423 · Cited by 12
Executive function deficit in patients with long COVID syndrome: A systematic review
Nasir, S. M., Yahya, N. A., Yap, K. H., & Manan, H. A. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e41987 · Cited by 14
“However, impaired EF was prevalent, irrespective of the clinical severity, with pulmonary function and respiratory symptoms post-recovery being associated with greater impairments [54,47].”
Montejo, L., Solé, B., Verdolini, N., Martínez‐Arán, A., Bonnín, C. D. M., Raduà, J., Martín‐Villalba, I., Williams, E., García‐Rizo, C., Mezquida, G., et al. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.07.006 · Cited by 12
Moretta, P., Ambrosino, P., Lanzillo, A., Marcuccio, L., Fuschillo, S., Papa, A., Santangelo, G., Trojano, L., & Maniscalco, M. (2022) · Healthcare · doi:10.3390/healthcare10030480 · Cited by 12
Cognitive phenotyping of post-infectious SARS-CoV-2 patients
Aiello, E. N., Radici, A., Mora, G., & Pain, D. (2022) · Neurological Sciences · doi:10.1007/s10072-022-06130-8 · Cited by 12
“Nonetheless, it must be noted that contrasting evidence has recently emerged as for ICU admission, namely that admitted patients may have worse cognitive outcomes [7].”
BackgroundTANTI, A. D., Conforti, J. M., Bruni, S., Gaetano, K. D., Cappalli, A., Basagni, B., Bertoni, D., & Saviola, D. (2023) · Neurological Sciences · doi:10.1007/s10072-023-06665-4 · Cited by 14
Braig, S., Peter, R. S., Nieters, A., Kräusslich, H., Brockmann, S., Göpel, S., Kindle, G. R., Merle, U., Steinacker, J. M., Kern, W. V., et al. (2023) · IJID Regions · doi:10.1016/j.ijregi.2023.11.015 · Cited by 12
“Interestingly, post-COVID cognitive impairment [30] or post-COVID fatigue and a reduced cognitive function were associated with not being able to return to work in 77 employees [31] , yet no similar association was found with post-COVID depression and anxiety [31] .”
ResultForet-Bruno, P., Shafran, R., Stephenson, T. J., Nugawela, M. D., Chan, D., Ladhani, S. N., McOwat, K., Mensah, A. A., Simmons, R., Fox‐Smith, L., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.05.001 · Cited by 13
“…impairment has been reported several months after SARS-CoV-2 infection, with reported deficits in verbal and executive function, attention, and memory(Becker et al. (2021); Graham et al., 2021; Hampshire et al., 2021; Jennings et al., 2022; Lamontagne et al., 2021; Miskowiak et al., 2021).”
Hagen, B. I., Lerdal, A., Søraas, A. V. L., Landrø, N. I., Bø, R., Småstuen, M. C., Becker, J., & Stubberud, J. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.106955 · Cited by 11
Corna, S., Giardini, M., Godi, M., Bellotti, L., & Arcolin, I. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192416383 · Cited by 11
“However, not only critical but also patients with severe COVID-19 can present multiorgan involvement, with cardiovascular, neurological, or skeletal muscular manifestations in addition to lung disease [10,11].”
BackgroundQuinn, B. (2023) · Critical Care Nurse · doi:10.4037/ccn2023507 · Cited by 10
Barilaite, E., Watson, H., & Hocaoğlu, M. (2024) · Journal of patient-centered research and reviews · doi:10.17294/2330-0698.2041 · Cited by 10
Long COVID: From olfactory dysfunctions to viral Parkinsonism
Pandey, S., Bapat, V., Abraham, J. N., & Abraham, N. M. (2024) · World Journal of Otorhinolaryngology - Head and Neck Surgery · doi:10.1002/wjo2.175 · Cited by 10
“61 66 Long ‐ term cardiovascular sequelae in the aftermath of COVID ‐ 19 infections heightens the chances of cerebrovascular disorders, and dysrhythmias.”
Melillo, A., Perrottelli, A., Caporusso, E., Coltorti, A., Giordano, G. M., Giuliani, L., Pezzella, P., Bucci, P., Mucci, A., Galderisi, S., et al. (2024) · European Psychiatry · doi:10.1192/j.eurpsy.2024.1770 · Cited by 15
“Another factor to be taken into account is that many of the included studies recruited subjects based on self-reported CI, but employed objective assessment tools for the pre – post evaluation of treatment efficacy [112 – 115].”
Backgroundvan Houwelingen, F., van Dellen, E., Visser‐Meily, J. M. A., Valkenet, K., Heijnen, G. H., Vernooij, L. M., Kerckhoffs, M. C., & Slooter, A. J. C. (2023) · Scientific Reports · doi:10.1038/s41598-023-41667-4 · Cited by 11
Is COVID-19 Infection a Multiorganic Disease? Focus on Extrapulmonary Involvement of SARS-CoV-2
Duloquin, G., Pommier, T., Georges, M., Giroud, M., Guénancia, C., Béjot, Y., Laurent, G., & Rabec, C. A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051397 · Cited by 12
“This was found both in patients with moderate and severe COVID-19 [41].”
BackgroundSocial impact of brain fog and analysis of risk factors: Long COVID in Japanese population
Shigematsu, L., Kimura, R., Terai, H., Mimura, Y., Ito, D., Bun, S., Namkoong, H., Asakura, T., Chubachi, S., Masaki, K., et al. (2024) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52139 · Cited by 10
Long-term brain fog and cognitive impairment in previously hospitalized COVID-19 patients
Junco, B., Samano, D., Karakeshishyan, V., Bass, D., Sobczak, E., Swafford, E. P., Saavedra, A. B., Rooks, J. D., Baumel, B. S., Ramos, A. R., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0309102 · Cited by 9
Cognitive function and brain structure in COVID-19 survivors: The role of persistent symptoms
Vakani, K., Norbury, R., Vanova, M., Ratto, M., Parton, A. D., Antonova, E., & Kumari, V. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115283 · Cited by 9
“With an incidence rate of > 50 %, this has been one of the most prevalent long-COVID symptom in many previous studies [33,48,61,64,74].”
Foreman, L. M., Child, B., Saywell, I., Collins‐Praino, L. E., & Baetu, I. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106067 · Cited by 12
“7 Miskowiak studies (Miskowiak et al., 2022; Miskowiak et al., 2021); data from four months post-COVID was used. study-level variables extracted for studies for which IPD was not obtained underwent comparative analysis with those for which IPD was obtained, as reported in Section 3.7.3.”
InfluentialEmerging Role of Mesenchymal Stromal Cell and Exosome Therapies in Treating Cognitive Impairment
Tew, V. K., Barathan, M., Nordin, F., Law, J. X., & Ng, M. H. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030284 · Cited by 9
“Emerging evidence links COVID-19 to cognitive decline, likely through mechanisms involving inflammation and oxidative stress [33].”
Kay, C. D., Costa, A. S., Vannorsdall, T. D., Aduen, P. A., Vila‐Castelar, C., Burstein, S. M., Pollak, L. E., Leibel, D. K., Sherman, J. C., Bungenberg, J., et al. (2022) · COVID · doi:10.3390/covid2090092 · Cited by 9
Using Machine Learning Algorithms to Determine the Post-COVID State of a Person by Their Rhythmogram
Викторович, С. С., Kovalchuk, A. V., Eremin, E. V., Drugova, O. V., Заречнова, Н. В., Tsirkova, M., Permyakov, S., Parin, S. B., & Polevaya, S. A. (2023) · Sensors · doi:10.3390/s23115272 · Cited by 9
Post-COVID-19 Cognitive Decline and Apoe Polymorphism: Towards a Possible Link?
Tavares-Júnior, J. W. L., Oliveira, D. N., da Silva, J. B. S., Feitosa, W. L. Q., Sousa, A. V. M., Marinho, S. C., Cunha, L. C. V., Gaspar, S. D. B., Gomes, C. M. P., de Oliveira, L. L. B., et al. (2023) · Brain Sciences · doi:10.3390/brainsci13121611 · Cited by 10
“Older adults were more susceptible to severe COVID-19 manifestations throughout the pandemic, which also puts this population at risk of cognitive decline after such more clinically severe conditions and also after hospitalization [41].”
BackgroundNeurocognitive and Neuropsychiatric Sequelae in Long COVID-19 Infection
Almería, M., Cejudo, J. C., Deus, J., & Krupiński, J. (2024) · Brain Sciences · doi:10.3390/brainsci14060604 · Cited by 9
Ramos‐Usuga, D., Perrin, P. B., Bogdanova, Y., Olabarrieta‐Landa, L., Alzueta, E., Baker, F. C., Iacovides, S., Cortes, M., & Arango‐Lasprilla, J. C. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191912593 · Cited by 9
“[17] evaluated the cognitive functioning of 29 individuals 3–4 months after hospital discharge for COVID-19 through the Trail Making Test (TMT) and the Screen for Cognitive Impairment in Psychiatry (SCIP).”
MethodNeuroprotective Agents with Therapeutic Potential for COVID-19
Zaa, C. A., Espitia, C., Reyes-Barrera, K. L., An, Z., & Velasco-Velázquez, M. A. (2023) · Biomolecules · doi:10.3390/biom13111585 · Cited by 9
“- Cognitive damage: COVID-19 can cause a cognitive deficit, mainly in attention and executive function, and verbal learning; and the incidence is associated with the severity of COVID-19 [68,69].”
BackgroundDemyelination in Patients with POST-COVID Depression
Khodanovich, M. Y., Светлик, М. В., Kamaeva, D. A., Usova, A. V., Kudabaeva, M., Anan’ina, T. V., Wasserlauf, I. E., Pashkevich, V., Moshkina, M., Obukhovskaya, V. B., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164692 · Cited by 8
Babnik, K., Staresinic, C., & Lep, Ž. (2022) · Human Systems Management · doi:10.3233/hsm-220003 · Cited by 10
“A smaller study by Miskowiak et al. [21] found that between 59 and 65% of its patients demonstrated clinically significant cognitive impairment, with verbal learning and executive functions being most affected, 3-4 months after hospital discharge.”
Latifi, A., & Jaroslav Flegr, A. (2023) · Biology Methods and Protocols · doi:10.1093/biomethods/bpad037 · Cited by 8
“Our results align with previous studies that have identified a correlation between COVID-19 severity and subsequent declines in physical health [35, 37–39], mental health challenges [7, 40, 41], and cognitive deficits [8, 42, 43].”
ResultCognitive performance of post-covid patients in mild, moderate, and severe clinical situations
Serafim, A. D. P., Saffi, F., Soares, A. R. A., Morita, A. M., Assed, M. M., de Toledo, S., Rocca, C. C. D. A., & Durães, R. S. S. (2024) · BMC Psychology · doi:10.1186/s40359-024-01740-7 · Cited by 12
“Overall, the COVID-19 pandemic significantly elevated stress and anxiety levels in both the general population and in patients with more severe symptoms requiring hospitalization [26, 28, 36, 45–49].”
BackgroundHighlighting the Neuropsychological Consequences of COVID-19: Evidence From a Narrative Review
Megari, K., Thomaidou, E., & Chatzidimitriou, E. (2024) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/00469580241262442 · Cited by 8
“12,15,17 In addition, some studies detected processing speed deficits.”
BackgroundGomzyakova, N. A., Palchikova, E. I., Tumova, M. A., Kasyanov, E. D., & Sorokin, M. Y. (2022) · Consortium Psychiatricum · doi:10.17816/cp189 · Cited by 8
“The severity of the COVID-19 course depends on the level of hypoxemia, increased concentration of D-dimer in the acute period, residual pulmonary insufficiency, the level of C-reactive protein (CRP), and increased density of the white matter of the brain [17].”
BackgroundCognitive Impairment and Risk Factors in Post-COVID-19 Hospitalized Patients
Khieukhajee, J., Rojana-udomsart, A., Srisarakorn, P., Wongsurit, T., & Aungsumart, S. (2023) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000531743 · Cited by 8
“However, previous studies reported con fl icted results regarding the association between these clinical biomarkers and cognitive symptoms [6 – 9 , The level of education seems to be the only predictive factor for post-acute COVID-19 cognitive symptoms in our research.”
BackgroundResultMcNeill, R., Marshall, R., Fernando, S. A., Harrison, O. K., & Machado, L. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.12.002 · Cited by 11
Profiles of Individuals With Long COVID Reporting Persistent Cognitive Complaints
Fernandez, C. C., Didone, V., Slama, H., Dupuis, G., Fery, P., Delrue, G., Lesoinne, A., Collette, F., & Willems, S. J. (2025) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acaf064 · Cited by 9
“Similarly,tomeasurecognitivecomplaints,severalstudies usedquestionnairesthatassessawiderangeofcognitive symptoms(e.g.,CognitiveFailuresQuestionnaireorEveryday CognitionQuestionnaire;Miskowiaketal.,2021;Marquine etal.,2023).”
Garmoe, W. S., Rao, K., Gorter, B. G., & Kantor, R. (2024) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acae017 · Cited by 7
Immune Response and Cognitive Impairment in Post-COVID Syndrome: A Systematic Review
Holland, J. F., Sheehan, D., Brown, S. A., O'Flanagan, S., Savinelli, S., O’Keeffe, F. M., & Bramham, J. (2024) · The American Journal of Medicine · doi:10.1016/j.amjmed.2024.09.022 · Cited by 7
Gamberini, G., Masuccio, F. G., Cerrato, M., Strazzacappa, M., Ferraro, D., & Solaro, C. M. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.12.100 · Cited by 7
Rahman, M. R., Akter, R., Neelotpol, S., Mayesha, I. I., & Afrose, A. (2023) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175231214974 · Cited by 8
“45,46,51-54 More importantly, COVID-19 induced neuronal damage is responsible for long-term cognitive impairments such as memory dif fi culties, inability to concentrate and focus, temporal orientation, task-set shifting, proactive control, and executive dysfunction.”
BackgroundAriza, M., Béjar, J., Barruè, C., Cano, N., Segura, B., NAUTILUS Project Collaborative Group, Bernia, J. A., Arauzo, V., Balagué‐Marmaña, M., Pérez-Pellejero, C., et al. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01748-x · Cited by 9
“In contrast to previous research [9, 22, 110, 111], our model revealed no effect of age or gender.”
Jung, J. H., Park, J., & Park, K.-H. (2024) · BMC Geriatrics · doi:10.1186/s12877-023-04646-y · Cited by 7
“According to previous studies, there is a correlation between depression, anxiety, and overall cognitive function [43] and there was an interaction between depression and cognitive function on quality of life [44].”
BackgroundWhat We Know About Neurocognitive Outcomes in Long-/Post-COVID-19 Adults
Seibert, S., Hanke, A., Wieberneit, M., Bieler, L., Gräfenkämper, R., Klatt, K., & Widmann, C. N. (2024) · Zeitschrift für Neuropsychologie · doi:10.1024/1016-264x/a000395 · Cited by 9
Hauke-Gleißner, J., Jarvers, I., Jordan, S., Gerling, S., Kabesch, M., Brunner, R., & Kandsperger, S. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-10813-w · Cited by 6
“Furthermore, there was an association between pulmonary dysfunction and cognitive deficits/deficits in executive functioning [24].”
Takács, J., Deák, D., Seregély, B., & Koller, Á. (2025) · Life · doi:10.3390/life15050821 · Cited by 6
“Our results are in line with previous studies [40,47,60], which revealed an association between cognitive dysfunction and reported cognitive complaints.”
Meyer, P., & Zaiser, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-04166-2 · Cited by 7
“Unlike earlier studies 5,6,13,101,102 , our findings indicate no difference in alertness or in most tasks evaluating executive functions such as updating, inhibition and flexibility (assessed through the n-back task, the stop-signal task, the go/no-go task, and task switching).”
Understanding the neurological implications of acute and long COVID using brain organoids
García‐González, L., Martí-Sarrias, A., Puertas, M. C., Bayón-Gil, Á., Resa‐Infante, P., Martínez‐Picado, J., Navarro, A., & Acosta, S. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.050049 · Cited by 7
“…to acute or relapsed SARS-CoV-2 infection (Box 1) (Buskermolen et al., 2021; Tillett et al., 2021), and/or persistent inflammation of the brain parenchyma upon systemic infection (Bertuccelli et al., 2022; Davidson et al., 2021; Mattioli et al., 2022; Miskowiak et al., 2021; Sneller et al., 2022).”
Jegatheeswaran, L., Gokani, S. A., Luke, L., Klyvyte, G., Espehana, A., Garden, E. M., Tarantino, A., Al‐Omari, B., & Philpott, C. M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1165329 · Cited by 6
Neurocognitive Changes in Patients with Post-COVID Depression
Khodanovich, M. Y., Naumova, A. V., Kamaeva, D. A., Obukhovskaya, V. B., Vasilieva, S., Schastnyy, E. D., Kataeva, N., Levina, A., Kudabaeva, M., Pashkevich, V., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051442 · Cited by 6
“The association of the severity of COVID-19 with long-term neurological consequences is well documented [16,22,25,61–64].”
BackgroundNeuropsychological functioning and its correlates at 1 year follow‐up of severe COVID ‐19
Costas‐Carrera, A., Sánchez‐Rodríguez, M. M., Ojeda, A., Rodríguez-Rey, A., Martín‐Villalba, I., Primé‐Tous, M., Valdesoiro‐Pulido, F., Segú, X., Borràs, R., Clougher, D., et al. (2024) · Psychogeriatrics · doi:10.1111/psyg.13113 · Cited by 6
“2,10,12 Conversely, other factors such as cognitive reserve may protect from cognitive impairment after SARS-CoV-2 infection.”
BackgroundCognitive impairment in long-COVID
Tozkir, J., Turkmen, Ç., & Topçular, B. (2024) · Ideggyógyászati Szemle · doi:10.18071/isz.77.0151 · Cited by 6
Reeves, R. R., & Willoughby, S. G. (2022) · Journal of Osteopathic Medicine · doi:10.1515/jom-2021-0195 · Cited by 6
Perrin, P. B., Ramos‐Usuga, D., West, S. J., Merced, K., Klyce, D. W., Lequerica, A. H., Olabarrieta‐Landa, L., Alzueta, E., Baker, F. C., Iacovides, S., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20010183 · Cited by 6
Manfredini, A., Pisano, F., Incoccia, C., & Marangolo, P. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20064889 · Cited by 6
Cognitive function in recovered COVID-19 Lebanese patients with schizophrenia
Haddad, C., Chamoun, A., Sacre, H., Hallit, S. R., Salameh, P., & Calvet, B. (2023) · Annals of General Psychiatry · doi:10.1186/s12991-023-00435-4 · Cited by 7
Willems, S. J., Didone, V., Fernandez, C. C., Delrue, G., Slama, H., Fery, P., Goin, J., Libera, C. D., COVCOG Group, Moutschen, M. P., et al. (2023) · BMC Neurology · doi:10.1186/s12883-023-03346-9 · Cited by 6
“These long-term difficulties still mainly concern processing speed and attentional functions, followed by memory in verbal and visual-spatial modalities [3, 5, 7].”
BackgroundInfluentialPoor sleep quality may trigger cognitive deficits after recovery from COVID-19
Carnes, A., Piñol‐Ripoll, G., Ariza, M., Cano, N., Segura, B., Junqué, C., Béjar, J., Barruè, C., Garolera, M., & Nautilus Project Collaborative Group (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1382875 · Cited by 6
Long-term cognitive functioning following COVID-19: Negligible neuropsychological changes over time
Koch, D. W., Klinkhammer, S., Verveen, A., Visser, D., Nieuwkerk, P. T., Verwijk, E., van Berckel, B. N. M., Horn, J., Tolboom, N., Heugten, C. M. V., et al. (2025) · The Clinical Neuropsychologist · doi:10.1080/13854046.2025.2496212 · Cited by 5
“This suggests the impact of initial disease severity on cognition may be limited, in line with some studies showing no differences in cognitive functioning between severely and non-severely impacted individuals (Miskowiak et al., 2021; Woo et al., 2020).”
Neurological manifestations of postcovid syndrome
Kamchatnov, P. R., Cheremin, R. A., Skipetrova, L. A., & Chugunov, A. V. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20221220317 · Cited by 5
Long COVID in Brain Health Research: A Call to Action
Rudroff, T. (2024) · Brain Sciences · doi:10.3390/brainsci14060587 · Cited by 5
“Mental health and cognition - COVID-19 is linked to high rates of sleep disturbance, anxiety, and mood disorders which impact cognition [10,13,23,45]; -”
BackgroundAlterações cognitivas e de memória na COVID-19: Revisão Integrativa da Literatura
Dias, B. C., Evangelista, L. C. R., Mazer, G. H. C., Ferraz, A. C. P. D. F., Tahan, V. C., & Higa, E. D. F. R. (2022) · New Trends in Qualitative Research · doi:10.36367/ntqr.13.2022.e708 · Cited by 5
Espinoza, C. S., & Martella, D. (2022) · Revista médica de Chile · doi:10.4067/s0034-98872022000600802 · Cited by 5
Lagravinese, G., Castellana, G., Castellana, F., Genco, M., Petrelli, R., Ruccia, M., Aliani, M., Carone, M., Sardone, R., & Battista, P. (2023) · Brain Sciences · doi:10.3390/brainsci13010084 · Cited by 5
“In an outpatient clinic, a report examined cognitive performance in 29 COVID-19 patients 3–4 months after their hospital discharge and found no correlation between the severity of COVID-19 infection, oxygen supplies needed, and cognitive impairments [14,27].”
BackgroundLong-Lasting COVID-Associated Brain Fog: A Follow-Up Study
Asadi‐Pooya, A. A., Shahisavandi, M., Nemati, H., Karimi, A., Jafari, A., Nasiri, S., Mohammadi, S. S., Nemati, M., Rahimian, Z., & Bayat, H. (2023) · European Neurology · doi:10.1159/000529860 · Cited by 5
Quantitative sensory testing defines the trajectory of sensory neuropathy after severe COVID-19
Ponirakis, G., Odriozola, A., Ortega, L., Martinez, L., Odriozola, S., Torrens, A., Coroleu, D., Martínez, S., Sanz, X., Ponce, M., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.111029 · Cited by 5
Demir, E., Veizi, B. G. Y., & Naharcı, M. İ. (2024) · Annals of Geriatric Medicine and Research · doi:10.4235/agmr.23.0186 · Cited by 5
“6) Post-intensive care syndrome, which manifests as the loss of cognitive and physical functions in patients who survive intensive care, may be responsible for some cognitive impairments caused by COVID-19.”
BackgroundCognitive performance in adults with post-COVID syndrome: Results from a German case-control study
Zülke, A. E., Luppa, M., Wirkner, K., Reusche, M., Sander, C., Büchner, R., Schomerus, G., Bergh, F. T., Lehmann, J., Witte, A. V., et al. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.06.036 · Cited by 5
Kwan, A. T. H., Lakhani, M., Le, G. H., Singh, G., Teopiz, K. M., Ceban, F., Nijjar, C. S., Meshkat, S., Badulescu, S., Ho, R., et al. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01877-x · Cited by 5
“…(subjective self reports on cognitive abilities versus objective performance on neuropsychological tests) are apparent in persons with PCC. [ 14, 15] However, the presence and magnitude of cognitive deficits reported are mixed, likely reflecting differences in method - ological approaches and…”
Su, H., Yang, P.-L., Eaton, T. L., Valley, T. S., Langa, K. M., Ely, E. W., & Thompson, H. J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0315425 · Cited by 5
Cognitive Sequelae of COVID ‐19: Mechanistic Insights and Therapeutic Approaches
Chen, Y., Jan, J., Yang, C., Yen, T., Linh, T. T. D., Annavajjula, S., Satapathy, M. K., Tsao, S., & Hsieh, C. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70348 · Cited by 5
“CI , particularly in the realm of executive functioning, has been strongly associated with reduced quality of life and heightened psychological distress in these individuals [5].”
Особливості когнітивних порушень при COVID-19
Kopchak, O. O. (2021) · INTERNATIONAL NEUROLOGICAL JOURNAL · doi:10.22141/2224-0713.17.3.2021.231569 · Cited by 6
Metadata
- Authors
- Miskowiak, K., Johnsen, S., Sattler, S., Nielsen, S., Kunalan, K., Rungby, J., Lapperre, T., & Porsberg, C.
- Affiliations
- Bispebjerg Hospital (DK)
- University of Copenhagen (DK)
- University of Antwerp (BE)
- Venue
- European Neuropsychopharmacology
- Publisher
- Elsevier BV
- Published
- 2021-05
- Volume
- 46
- Pages
- 39-48
- ISSN
- 0924-977X (ISSN-L)
- PMC
- PMC8006192
- OpenAlex
- W3148312871
- Cited by
- 365
- References
- 45
- Citations by year
- 2026: 12 · 2025: 45 · 2024: 60 · 2023: 97 · 2022: 115 · 2021: 36
- FWCI
- 36.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- European Neuropsychopharmacology (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- Funders
- Lundbeck Foundation
- Topics
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- COVID-19 pandemic, long COVID, cognitive impairment, hospital discharge, subjective cognitive complaints, quality of life, executive function, verbal learning, D-dimer, pulmonary dysfunction, cerebral oxygen delivery, cognitive screening
- MeSH terms
- COVID-19, Aged, Denmark, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Middle Aged, Patient Discharge, Prospective Studies, Severity of Illness Index, Time Factors, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review